Who has been buying metacare stock?

1 distinct insiders have filed 0 disclosed insider purchases in metacare (118000), most recently on 2026-06-19. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does metacare have?

metacare has 0 buy-side and 7 sell-side disclosures on record, covering ₩1.2B ($849K) in total reported value, spanning 2024-06-25 to 2026-06-19.

Where does StockDrifts get metacare insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

metacare 118000

Company

메타케어metacare

Insiders

Buys

Total Value

₩1.2B ($849K)

Avg Return

+11.41%

Last Filing

2026-06-19

metacare (118000) has 0 disclosed insider purchases and 7 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩1.2B ($849K) in reported transaction value. The earliest filing StockDrifts holds for metacare is dated 2024-06-25; the most recent is 2026-06-19. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +11.41%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-06-19	BUY	제3자배정유상증자	메타랩스 Metalapse	-	4.9M	₩1,429	-13.9%	₩7.0B ($4.8M)
2026-04-28	SELL	자본감소	메타랩스 Metalapse	-	-57.6M	₩208	+0.0%	₩12.0B ($8.3M)
2025-06-21	BUY	제3자배정유상증자	메타랩스 Metalapse	-	7.0M	₩331	-4.2%	₩2.3B ($1.6M)
2025-06-19	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-63.0K	₩349	+9.2%	₩22M ($15K)
2025-06-18	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-693.4K	₩354	+10.4%	₩245M ($170K)
2025-06-13	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-10.0K	₩347	+8.7%	₩3M ($2K)
2025-05-30	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-144.6K	₩343	+7.6%	₩50M ($34K)
2025-05-29	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-227.5K	₩350	+9.4%	₩80M ($55K)
2025-04-21	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-2.0M	₩327	+3.1%	₩656M ($455K)
2024-08-12	BUY	기타	메타랩스 Metalapse	-	22.0M	₩409	-22.5%	₩9.0B ($6.2M)
2024-08-12	SELL	전환등	메타랩스 Metalapse	-	-11.1M	₩409	+22.5%	₩4.5B ($3.2M)
2024-08-05	SELL	장외매도	초록뱀미디어 Chorokbaem Media	-	-35.0M	₩396	+19.9%	₩13.9B ($9.6M)
2024-08-05	SELL	장외매도	초록뱀미디어 Chorokbaem Media	-	-11.1M	₩396	+19.9%	₩4.4B ($3.1M)
2024-08-05	BUY	장외매수	메타랩스 Metalapse	-	35.0M	₩396	-19.9%	₩13.9B ($9.6M)
2024-08-05	BUY	장외매수	메타랩스 Metalapse	-	11.1M	₩396	-19.9%	₩4.4B ($3.1M)
2024-06-25	SELL	Market Sell	청담메이힐스신기술조합 Cheongdam Mayhills New Technology Association	-	-359.4K	₩463	+31.5%	₩166M ($116K)

Frequently asked questions

Who has been buying metacare stock?: 1 distinct insiders have filed 0 disclosed insider purchases in metacare (118000), most recently on 2026-06-19. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does metacare have?: metacare has 0 buy-side and 7 sell-side disclosures on record, covering ₩1.2B ($849K) in total reported value, spanning 2024-06-25 to 2026-06-19.
Where does StockDrifts get metacare insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for metacare. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.